Paper22326705
Skin-PAMPA: a new method for fast prediction of skin penetration.
Sinkó B and 6 others. Eur J Pharm Sci, 2012. Cited by 128 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Skin-PAMPA: a new method for fast prediction of skin penetration. Papers, record 22326705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22326705
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Membrane Lipids | Major topic |
| Membranes, Artificial | Major topic |
| Models, Biological | Major topic |
| Skin | Major topic |
| Administration, Cutaneous | |
| Adult | |
| Cell Membrane Permeability | |
| Ceramides | |
| Databases, Factual | |
| Drug Discovery | |
| Humans | |
| Lipid Metabolism | |
| Middle Aged | |
| Reproducibility of Results | |
| Skin Absorption |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,471,100 | Cracking the Skin Barrier: Models and Methods Driving Dermal Drug Delivery. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41471100 | PubMed |
| 41,321,381 | Comparison of lipophilic and size-exclusion membranes: creating sink conditions with cyclodextrin. | ADMET DMPK | 2025 | https://conductscience.org/library/papers/41321381 | PubMed |
| 41,292,376 | Effective Penetration of the Oxidized Keratin-Rebonding Materials Into Hair Shafts Based on Charge Conversion. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41292376 | PubMed |
| 40,786,063 | Comparison of lipophilic and size-exclusion membranes: the effect of stirring and cyclodextrin in the donor compartment. | ADMET DMPK | 2025 | https://conductscience.org/library/papers/40786063 | PubMed |
| 39,795,193 | Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? | Molecules | 2025 | https://conductscience.org/library/papers/39795193 | PubMed |
| 38,933,176 | New Skin-Relevant Cell Coculture Model With Stratum Corneum-Like Layer. | Biomed Res Int | 2024 | https://conductscience.org/library/papers/38933176 | PubMed |
| 38,931,938 | Progress in Topical and Transdermal Drug Delivery Research-Focus on Nanoformulations. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38931938 | PubMed |
| 38,931,927 | Lipid Biomimetic Models as Simple Yet Complex Tools to Predict Skin Permeation and Drug-Membrane Biophysical Interactions. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38931927 | PubMed |
| 37,765,241 | Optical Methods for Non-Invasive Determination of Skin Penetration: Current Trends, Advances, Possibilities, Prospects, and Translation into In Vivo Human Studies. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765241 | PubMed |
| 37,505,006 | Evaluation of the Ability of PAMPA Membranes to Emulate Biological Processes through the Abraham Solvation Parameter Model. | Membranes (Basel) | 2023 | https://conductscience.org/library/papers/37505006 | PubMed |
| 37,315,744 | Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro. | Toxicol In Vitro | 2023 | https://conductscience.org/library/papers/37315744 | PubMed |
| 37,111,632 | Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111632 | PubMed |
| 36,986,760 | Natural Lipid Extracts as an Artificial Membrane for Drug Permeability Assay: In Vitro and In Silico Characterization. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986760 | PubMed |
| 36,959,412 | A Comparative Analysis of Biological and Synthetic Skin Models for Drug Transport Studies. | Pharm Res | 2023 | https://conductscience.org/library/papers/36959412 | PubMed |
| 36,778,642 | Development of artificial neural network models to predict the PAMPA effective permeability of new, orally administered drugs active against the coronavirus SARS-CoV-2. | Netw Model Anal Health Inform Bioinform | 2023 | https://conductscience.org/library/papers/36778642 | PubMed |
| 36,756,221 | Passive Enhancement of Retinol Skin Penetration by Jojoba Oil Measured Using the Skin Parallel Artificial Membrane Permeation Assay (Skin-PAMPA): A Pilot Study. | Clin Cosmet Investig Dermatol | 2023 | https://conductscience.org/library/papers/36756221 | PubMed |
| 36,432,678 | Topical Semisolid Products-Understanding the Impact of Metamorphosis on Skin Penetration and Physicochemical Properties. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36432678 | PubMed |
| 36,171,345 | Transdermal Delivery of Metformin Utilizing Ionic Liquid Technology: Insight Into the Relationship Between Counterion Structures and Properties. | Pharm Res | 2022 | https://conductscience.org/library/papers/36171345 | PubMed |
| 36,145,644 | Self-Emulsifying Phospholipid Preconcentrates for the Enhanced Photoprotection of Luteolin. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36145644 | PubMed |
| 35,583,641 | Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/35583641 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22326705
GET https://conductscience.org/api/papers/v1/22326705/cited_by?page=2